DOH, LGUs and Partners to Conduct Phase 2 of Month-long Nationwide MR-OPV SIA Starting February 1
Format
Joint press release
CAVITE, Philippines – After a successful nationwide Measles Rubella and Oral Polio Vaccine Supplemental Immunization Activity (MR-OPV SIA) Phase I last year in the Mindanao, Cordillera, Ilocos, Cagayan Valley, MIMAROPA and Bicol Regions with a coverage of 93% for Measles Rubella (MR) Vaccine and 89% for Oral Polio Vaccine (OPV), the Phase 2 of the vaccination campaign will be conducted from February 1 to 28, 2021 in the Visayas Regions, National Capital Region, Central Luzon and CALABARZON. The Phase 2 MR-OPV SIA aims to vaccinate 5.1 million 9-59 months old children for the Measles Rubella (MR) vaccine and 4.8 million children 0-59 months old for Oral Polio vaccine (OPV).
DOH, LGUs and partners to conduct Phase II of month-long nationwide measles-rubella and oral polio vaccine campaign starting February 1
DOH, LGUs and partners to conduct Phase II of month-long nationwide measles-rubella and oral polio vaccine campaign starting February 1 28 January 2021
Joint News Release
After a successful nationwide measles-rubella and oral polio vaccine supplemental immunization activity (MR-OPV SIA) Phase I last year in the Mindanao, Cordillera, Ilocos, Cagayan Valley, MIMAROPA and Bicol Regions with a coverage of 93% for Measles-Rubella (MR) Vaccine and 89% for Oral Polio Vaccine (OPV), the Phase II of the vaccination campaign will be conducted from February 1 to 28, 2021 in the Visayas Regions, National Capital Region, Central Luzon and CALABARZON. The Phase 2 MR-OPV SIA aims to vaccinate 5.1 million 9-59 months old children for the MR vaccine and 4.8 million children 0-59 months old for OPV.
Abstract
Since May 2019, the Central African Republic has experienced a poliomyelitis outbreak caused by type 2 vaccine-derived polioviruses (VDPV-2s). The outbreak affected Bangui, the capital city, and 10 districts across the country. The outbreak resulted from several independent emergence events of VDPV-2s featuring recombinant genomes with complex mosaic genomes. The low number of mutations ( 20) in the viral capsid protein 1–encoding region compared with the vaccine strain suggests that VDPV-2 had been circulating for a relatively short time (probably 3 years) before being isolated. Environmental surveillance, which relies on a limited number of sampling sites in the Central African Republic and does not cover the whole country, failed to detect the circulation of VDPV-2s before some had induced poliomyelitis in children.
Polio Vaccines Polio can be prevented with a vaccine. Since 2000, the inactivated polio vaccine (IPV) is most often given in the USA. It is administered by a shot in the arm or leg, depending on the person’s age, says the U.S. CDC. The CDC recommends that children get polio vaccinated to protect against poliomyelitis.
Dec 24, 2020 (Heraldkeepers)
The growth of the market is attributed to the rising prevalence of diseases, increasing government and nongovernment funding.